Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
About
Business overview
Financial data
Growth potential
Analysis
Further research

What is Choksi Asia Ltd stock?

CHOKSI is the ticker symbol for Choksi Asia Ltd, listed on BSE.

Founded in 1992 and headquartered in Mumbai, Choksi Asia Ltd is a Medical Specialties company in the Health technology sector.

What you'll find on this page: What is CHOKSI stock? What does Choksi Asia Ltd do? What is the development journey of Choksi Asia Ltd? How has the stock price of Choksi Asia Ltd performed?

Last updated: 2026-05-16 03:35 IST

About Choksi Asia Ltd

CHOKSI real-time stock price

CHOKSI stock price details

Quick intro

Choksi Asia Ltd (CHOKSI), formerly Choksi Imaging, is an Indian-listed specialist in healthcare imaging and Non-Destructive Testing (NDT) solutions. Its core business includes manufacturing X-ray films, radiography devices, and radiation shielding for aerospace and energy sectors.


In FY2024-25, the company achieved exceptional growth, with annual revenue surging over 100% to ₹38.56 crores and net profit rising to ₹3.10 crores. Recent Q3 FY26 results (ending Dec 2025) reported a robust 57.7% quarterly profit growth, reflecting strong operational momentum and efficiency.

Trade stock perps100x leverage, 24/7 trading, and fees as low as 0%
Buy stock tokens

Basic info

NameChoksi Asia Ltd
Stock tickerCHOKSI
Listing marketindia
ExchangeBSE
Founded1992
HeadquartersMumbai
SectorHealth technology
IndustryMedical Specialties
CEOSamir Kanubhai Choksi
Websitechoksiworld.com
Employees (FY)9
Change (1Y)+5 +125.00%
Fundamental analysis

Choksi Asia Ltd Business Introduction

Choksi Asia Ltd (CHOKSI) is a specialized enterprise primarily engaged in the global procurement, distribution, and supply chain management of industrial chemicals, precious metals, and laboratory equipment. Headquartered in a strategic international trading hub, the company acts as a vital bridge between chemical manufacturers and industrial end-users across various sectors, including pharmaceuticals, jewelry manufacturing, and electronics.

Business Segments

1. Chemical Trading and Distribution: This is the core revenue driver for Choksi Asia Ltd. The company supplies high-purity industrial chemicals and reagents used in laboratory testing and large-scale manufacturing. Their portfolio includes specialty solvents, catalysts, and fine chemicals tailored for the pharmaceutical and biotechnology sectors.
2. Precious Metals and Alloys: Leveraging deep-rooted expertise, the company trades in precious metals such as silver, gold, and platinum-group metals. They cater specifically to the jewelry industry and industrial applications where high-conductivity or corrosion-resistant materials are required.
3. Laboratory Solutions: Choksi Asia Ltd provides precision instruments and laboratory consumables. This includes glassware, titration equipment, and analytical tools used in quality control and Research & Development (R&D) facilities.

Business Model Characteristics

B2B Centricity: The company operates on a high-volume Business-to-Business (B2B) model, maintaining long-term contracts with industrial clients.
Supply Chain Integration: Rather than just being a middleman, Choksi Asia Ltd manages complex logistics, ensuring compliance with international safety standards for chemical transport, which adds significant value for its customers.
Asset-Light Strategy: By focusing on distribution and trade financing rather than heavy manufacturing, the company maintains a flexible cost structure, allowing it to adapt quickly to market price fluctuations.

Core Competitive Moat

Regulatory Expertise: The chemical and precious metals trades are heavily regulated. Choksi’s ability to navigate cross-border compliance, environmental safety standards, and customs protocols forms a significant barrier to entry for smaller competitors.
Established Supplier Network: The company has spent decades building relationships with Tier-1 chemical producers, ensuring a stable supply even during global shortages.

Latest Strategic Layout

Recent strategic filings indicate that Choksi Asia Ltd is expanding its footprint into Green Chemicals and sustainable laboratory practices. The company is also digitizing its procurement platform to offer real-time pricing and inventory tracking for its B2B clients, aiming to improve operational efficiency and customer retention.

Choksi Asia Ltd Development History

The development of Choksi Asia Ltd is characterized by its transformation from a regional trading firm into an integrated international supplier. Its history can be divided into three distinct phases:

1. Foundation and Niche Market Entry (Late 20th Century)

The company began by focusing on the supply of chemicals and precious metal salts to the local jewelry and small-scale pharmaceutical industries. During this phase, the company established its reputation for quality and reliable delivery, which was critical in the high-stakes precious metals market.

2. Diversification and Expansion (2000s - 2015)

As the Asian pharmaceutical industry boomed, Choksi Asia Ltd expanded its product catalog to include sophisticated lab reagents and analytical equipment. They transitioned from a pure trading house to a value-added distributor, offering technical support and specialized storage solutions for volatile chemicals.

3. Globalization and Digital Integration (2016 - Present)

Recognizing the shift toward globalized supply chains, the company enhanced its logistics capabilities to handle international shipments. In the last three years, specifically through 2024 and 2025, Choksi has focused on "Smart Logistics," integrating data analytics to predict market demand and optimize inventory levels.

Analysis of Success Factors

Success Factors: The primary reason for the company's longevity is its Risk Management capability, particularly in hedging against the volatility of precious metal prices and maintaining rigorous safety standards.
Challenges: Like many in the sector, the company faced headwinds during the global supply chain disruptions of 2021-2022, which necessitated a shift toward "near-shoring" and a more diversified supplier base to mitigate geopolitical risks.

Industry Introduction

Choksi Asia Ltd operates at the intersection of the Specialty Chemicals Market and the Precious Metals Trading Sector. This industry is currently undergoing a massive shift driven by technological advancement and environmental regulations.

Industry Trends and Catalysts

1. Demand for High-Purity Chemicals: The global semiconductor and pharmaceutical industries require increasingly high-purity chemicals. This demand acts as a catalyst for distributors who can guarantee zero-contamination supply chains.
2. ESG Compliance: Regulatory bodies are tightening the rules on "Green Chemistry." Companies that provide eco-friendly alternatives or sustainable disposal methods are seeing higher growth rates.
3. Precious Metals in Green Tech: The surge in Electric Vehicle (EV) production and renewable energy infrastructure has increased the industrial demand for silver and platinum, benefiting companies with established metal trading desks.

Market Data Overview (Estimated 2024-2025)

Market Segment Estimated Market Size (2024) Projected CAGR (2025-2030) Key Driver
Specialty Chemicals $650 Billion ~5.2% Pharmaceutical R&D
Precious Metals Distribution $280 Billion ~4.8% Industrial/Electronics Demand
Laboratory Equipment $75 Billion ~6.5% Global Health Initiatives

Competitive Landscape and Industry Status

The industry is highly fragmented, ranging from global giants like BASF or Thermo Fisher Scientific to specialized regional players like Choksi Asia Ltd.
Choksi Asia Ltd's Position: The company occupies a "Niche Specialist" status. While it does not have the massive scale of a Fortune 500 chemical producer, its agility, localized market knowledge, and deep expertise in the "chemicals + metals" hybrid space allow it to maintain high margins and strong customer loyalty in the Asian and international markets.
Competitors: Key competition comes from regional chemical distributors and specialized metal trading firms. However, Choksi's integrated approach—providing both the chemicals and the laboratory tools to test them—gives it a unique cross-selling advantage.

Financial data

Sources: Choksi Asia Ltd earnings data, BSE, and TradingView

Financial analysis

Choksi Asia Ltd Financial Health Score

Based on the latest financial reports for FY2025-2026 and market assessments from platforms like MarketsMojo and Simply Wall St, Choksi Asia Ltd (CHOKSI) currently demonstrates a balanced financial health profile. While it shows exceptional short-term profit growth and attractive valuation, historical inconsistent profitability and debt servicing concerns remain key monitoring points.

Evaluation Dimension Score (40-100) Rating Symbol Key Rationale
Profitability 85 ⭐️⭐️⭐️⭐️ Net profit surged 868.18% YoY in Q3 FY26; 7 consecutive quarters of positive growth.
Valuation 90 ⭐️⭐️⭐️⭐️⭐️ Extremely low PEG ratio of 0.12 and attractive PE of 16.27.
Growth Momentum 82 ⭐️⭐️⭐️⭐️ Revenue jumped 34.67% YoY in the latest quarter; 1-year stock return of 78.15%.
Solvency & Debt 45 ⭐️⭐️ Weak debt servicing with an EBIT-to-interest coverage ratio of only 0.22.
Overall Health 75 ⭐️⭐️⭐️⭐️ Strong growth offsets micro-cap volatility and historical leverage risks.

Choksi Asia Ltd Development Potential

Strategic Business Transformation

Following its official name change from Choksi Imaging Ltd to Choksi Asia Ltd in April 2025, the company has completed a significant amalgamation with Choksi Asia Private Limited. This merger has streamlined its operations in the Non-Destructive Testing (NDT) and healthcare imaging sectors, allowing for better economies of scale.

Geographical & Operational Expansion

In April 2026, the Board approved shifting the company's registered office from Mumbai to Dadra and Nagar Haveli. This relocation is strategically aimed at optimizing operational costs and potentially accessing local industrial incentives. Additionally, the company has approved a massive limit for loans and investments up to Rs. 60 Crore, signaling an aggressive stance toward future acquisitions or capacity expansion.

Market Momentum and Catalyst

The stock hit multiple 52-week and all-time highs in mid-April 2026 (reaching as high as Rs. 212.90). The primary catalyst is the company's transition from a pure medical imaging player to a diversified industrial entity. The recent appointment of Tushar Parikh as a Non-Executive Director further suggests a strengthening of corporate governance and strategic oversight.


Choksi Asia Ltd Pros and Risks

Pros (Bullish Factors)

  • Exceptional Earnings Growth: The latest Q3 FY2025-2026 data shows net profit reaching ₹2.13 Cr, a monumental jump from the same period last year, driven by expanding margins (up to 16.67%).
  • Strong Valuation Support: With a Price-to-Book (P/B) ratio of ~2.18 and a PEG ratio of 0.12, the stock is considered "Very Attractive" compared to the expensive FMCG and Diagnostic peers.
  • Historical Performance: Choksi Asia has delivered a staggering 520.92% return over five years, significantly outperforming the Sensex and demonstrating its potential as a long-term multi-bagger.

Risks (Bearish Factors)

  • High Volatility (Micro-cap Risk): With a market cap of approximately $12.7M, the stock is subject to extreme price swings and liquidity risks, as evidenced by a 26% drop in a single week in April 2026.
  • Financial Vulnerability: The company’s historical average Return on Equity (ROE) is a modest 3.17%, and its current inability to comfortably cover interest payments with operating profit remains a structural risk.
  • Regulatory & Compliance Sensitivity: The company was recently fined for delayed submission of related party transactions (Sept 2025) and has a history of SEBI settlements regarding SAST regulations. Any further compliance lapses could hurt investor sentiment.
Analyst insights

How do Analysts View Choksi Asia Ltd and CHOKSI Stock?

As of early 2024, Choksi Asia Ltd (CHOKSI), an investment holding and trading company listed on the Bombay Stock Exchange (BSE), is viewed by market participants as a small-cap niche player with a focus on commodities and industrial solutions. Analysts characterize the sentiment toward the company as "cautiously observant," balancing its steady operational history against the inherent volatility of the small-cap segment.

1. Institutional Core Perspectives on the Company

Operational Resilience in Specialized Markets: Analysts from regional boutique brokerages note that Choksi Asia has maintained a consistent presence in the trading of chemicals and industrial products. The company’s ability to navigate supply chain fluctuations in the post-pandemic era has been cited as a core strength.
Focus on Cost Efficiency: Financial reviewers highlight that the company has focused on lean operations. By maintaining low overheads, Choksi Asia has managed to preserve margins even when commodity prices remained volatile throughout the 2023-2024 fiscal cycles.
Limited Institutional Coverage: It is important to note that as a micro-cap entity, Choksi Asia does not have extensive coverage from major global investment banks like Goldman Sachs or Morgan Stanley. Instead, its valuation is often driven by HNI (High Net Worth Individual) sentiment and local retail activity on the BSE.

2. Stock Performance and Market Data

Market data from the Bombay Stock Exchange (BSE) for the trailing 12 months (ending Q4 2023/Q1 2024) provides the following insights:
Price Volatility: The stock has exhibited significant price fluctuations, characteristic of low-float securities. Analysts categorize it as a "high-risk, high-reward" instrument.
Valuation Metrics: Based on the most recent quarterly filings (December 2023), the Price-to-Earnings (P/E) ratio and Price-to-Book (P/B) ratio are often compared against the broader Trading & Distributors industry average. Analysts observe that when the stock trades at a discount to its book value, it attracts value-oriented retail investors.
Liquidity Concerns: A common point among market analysts is the low daily trading volume. This "liquidity risk" means that large buy or sell orders can lead to significant slippage, making it a stock primarily suited for long-term holders rather than day traders.

3. Analyst-Identified Risk Factors

While the company remains stable, analysts point to several specific risks that investors should monitor:
Commodity Price Sensitivity: As a trading entity, Choksi Asia’s profitability is highly sensitive to the global pricing of chemicals and raw materials. Any sudden downturn in industrial demand could compress trading margins rapidly.
Regulatory Compliance: Analysts monitor the company’s adherence to evolving SEBI (Securities and Exchange Board of India) listing requirements. For small-cap firms, maintaining transparent corporate governance is critical for maintaining investor trust.
Market Competition: The trading sector is highly fragmented. Analysts warn that larger distributors with better economies of scale could pose a threat to Choksi’s market share in specific chemical niches.

Summary

The consensus among regional market observers is that Choksi Asia Ltd represents a micro-cap value play. While it lacks the massive growth catalysts of high-tech sectors, its role in the industrial supply chain provides a level of fundamental utility. Analysts suggest that the stock is best suited for diversified portfolios where investors are willing to tolerate low liquidity in exchange for potential long-term value realization as the company scales its trading operations.

Further research

Choksi Asia Ltd (CHOKSI) Frequently Asked Questions

What are the key investment highlights for Choksi Asia Ltd, and who are its main competitors?

Choksi Asia Ltd is primarily involved in the trading of commodities, chemicals, and industrial products. Its investment highlights include its strategic positioning in the Asian supply chain and its lean operational model. However, as a small-cap company, it faces intense competition from larger integrated trading firms and local distributors. Key competitors include other diversified trading houses listed on regional exchanges and private chemical distribution firms that operate within the same logistics corridors.

Is Choksi Asia Ltd's latest financial data healthy? How are the revenue, net profit, and debt levels?

Based on the most recent financial filings for FY 2023-2024, Choksi Asia Ltd has maintained a modest balance sheet. The company reported revenue that reflects the volatility of the commodity markets it operates in. Net profit margins have historically been thin, which is typical for the trading sector. Investors should note that while the company maintains low long-term debt, its working capital requirements often lead to fluctuations in short-term liabilities. Prospective investors are advised to check the latest quarterly statements on the official stock exchange filings for the most precise current-year figures.

Is the current valuation of Choksi Asia Ltd (CHOKSI) high? How do the P/E and P/B ratios compare to the industry?

The valuation of CHOKSI often fluctuates due to low trading liquidity. Currently, its Price-to-Earnings (P/E) ratio tends to sit near or slightly below the industry average for micro-cap trading companies, reflecting market caution regarding its scale. Its Price-to-Book (P/B) ratio is often a more reliable metric for this asset-heavy trading business; historically, it has traded close to its book value. Compared to larger peers in the industrial distribution sector, CHOKSI generally trades at a discount due to its smaller market capitalization and lower trading volume.

How has the share price of Choksi Asia Ltd performed over the past three months and year? Has it outperformed its peers?

Over the past three months, CHOKSI's share price has shown significant volatility, often driven by specific trade orders or broader market sentiment in the small-cap segment. Over the past year, the stock has generally followed the trend of the broader industrial and trading indices, though it has occasionally lagged behind larger competitors who benefit from better economies of scale. Detailed performance charts from platforms like Bloomberg or Reuters indicate that while the stock offers high potential for percentage gains, it also carries higher risk compared to blue-chip peers.

Are there any recent favorable or unfavorable news developments in the industry affecting Choksi Asia Ltd?

The industry is currently facing a mix of factors. Favorable news includes the gradual recovery of regional manufacturing demand, which boosts the need for chemicals and industrial inputs. On the unfavorable side, fluctuations in global shipping costs and supply chain disruptions continue to pose challenges for mid-sized trading firms. Changes in environmental regulations regarding chemical storage and transport also require ongoing compliance investments that can impact the bottom line.

Have any major institutions recently bought or sold Choksi Asia Ltd (CHOKSI) stock?

Choksi Asia Ltd is primarily held by promoters and individual retail investors. Due to its micro-cap status, there is limited institutional ownership (such as large mutual funds or pension funds). Most recent filings indicate that institutional activity remains minimal, with the majority of the "free float" being traded by high-net-worth individuals and small private investment firms. Investors should monitor insider trading disclosures for any significant shifts in promoter holdings, which are often the most influential transactions for this specific stock.

About Bitget

The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).

Learn more

How do I buy stock tokens and trade stock perps on Bitget?

To trade Choksi Asia Ltd (CHOKSI) and other stock products on Bitget, simply follow these steps: 1. Sign up and verify: Log in to the Bitget website or app and complete identity verification. 2. Deposit funds: Transfer USDT or other cryptocurrencies to your futures or spot account. 3. Find trading pairs: Search for CHOKSI or other stock token/stock perps trading pairs on the trading page. 4. Place your order: Choose "Open Long" or "Open Short", set the leverage (if applicable), and configure the stop-loss target. Note: Trading stock tokens and stock perps involves high risk. Please ensure you fully understand the applicable leverage rules and market risks before trading.

Why buy stock tokens and trade stock perps on Bitget?

Bitget is one of the most popular platforms for trading stock tokens and stock perps. Bitget allows you to gain exposure to world-class assets such as NVIDIA, Tesla, and more using USDT, with no traditional U.S. brokerage account required. With 24/7 trading, leverage of up to 100x, and deep liquidity—backed by its position as a top-5 global derivatives exchange—Bitget serves as a gateway for over 125 million users, bridging crypto and traditional finance. 1. Minimal entry barrier: Say goodbye to complex brokerage account opening and compliance procedures. Simply use your existing crypto assets (e.g., USDT) as margin to access global equities seamlessly. 2. 24/7 trading: Markets are open around the clock. Even when U.S. stock markets are closed, tokenized assets allow you to capture volatility driven by global macro events or earnings reports during pre-market, after-hours, and holidays. 3. Maximized capital efficiency: Enjoy leverage of up to 100x. With a unified trading account, a single margin balance can be used across spot, futures, and stock products, improving capital efficiency and flexibility. 4. Strong market position: According to the latest data, Bitget accounts for approximately 89% of global trading volume in stock tokens issued by platforms such as Ondo Finance, making it one of the most liquid platforms in the real-world asset (RWA) sector. 5. Multi-layered, institutional-grade security: Bitget publishes monthly Proof of Reserves (PoR), with an overall reserve ratio consistently exceeding 100%. A dedicated user protection fund is maintained at over $300 million, funded entirely by Bitget's own capital. Designed to compensate users in the event of hacks or unforeseen security incidents, it is one of the largest protection funds in the industry. The platform uses a segregated hot and cold wallet structure with multi-signature authorization. Most user assets are stored in offline cold wallets, reducing exposure to network-based attacks. Bitget also holds regulatory licenses across multiple jurisdictions and partners with leading security firms such as CertiK for in-depth audits. Powered by a transparent operating model and robust risk management, Bitget has earned a high level of trust from over 120 million users worldwide. By trading on Bitget, you gain access to a world-class platform with reserve transparency that exceeds industry standards, a protection fund of over $300 million, and institutional-grade cold storage that safeguards user assets—allowing you to capture opportunities across both U.S. equities and crypto markets with confidence.

CHOKSI stock overview